Skip to content

Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, sold MPLT on Jul 15, 2026

Data as of Oct 16

▼ SELL$167K4,510 shares at $36.94Anatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.
Watch MPLT
Traded
Jul 15, 2026
Disclosed
Jul 20, 2026
Filed
5 days after the trade · late

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, sold MPLT on Jul 15, 2026TRADEDDISCLOSED
MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day
MPLT since disclosure
−78.6%
after the sale
Similar stocks (XLV) since disclosure
+11.0%
XLV — its sector index fund

Change in closing price from Jul 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$7.7Kdisclosed Jul 20 · filed 3 days after the trade
  2. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$105Kdisclosed Jul 20 · filed 3 days after the trade
  3. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$533Kdisclosed Jul 20 · filed 3 days after the trade
  4. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$274Kdisclosed Jul 20 · filed 4 days after the trade
  5. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$59.6Kdisclosed Jul 20 · filed 4 days after the trade
  6. ▼ SELLAnatol Kreitzer Chief Discovery OfficerMPLT MapLight Therapeutics, Inc.$200Kdisclosed Jul 20 · filed 5 days after the trade · late

See every trade on MPLT →